Lee, J., Park, H. E., Jin, H., Jin, L., Yoo, S. Y., Cho, N., . . . Kang, G. H. The combination of CDX2 expression status and tumor-infiltrating lymphocyte density as a prognostic factor in adjuvant FOLFOX-treated patients with stage III colorectal cancers. Korean Society of Pathologists & the Korean Society for Cytopathology.
Chicago Style (17th ed.) CitationLee, Ji-Ae, Hye Eun Park, Hye-Yeong Jin, Lingyan Jin, Seung Yeon Yoo, Nam-Yun Cho, Jeong Mo Bae, Jung Ho Kim, and Gyeong Hoon Kang. The Combination of CDX2 Expression Status and Tumor-infiltrating Lymphocyte Density as a Prognostic Factor in Adjuvant FOLFOX-treated Patients with Stage III Colorectal Cancers. Korean Society of Pathologists & the Korean Society for Cytopathology.
MLA (9th ed.) CitationLee, Ji-Ae, et al. The Combination of CDX2 Expression Status and Tumor-infiltrating Lymphocyte Density as a Prognostic Factor in Adjuvant FOLFOX-treated Patients with Stage III Colorectal Cancers. Korean Society of Pathologists & the Korean Society for Cytopathology.